Invested $55 Million in BioNTech Before COVID-19
Gates made a $55 million pre-IPO equity investment in BioNTech, the German biotech company developing mRNA-based vaccines for HIV, tuberculosis, and influenza. The stake predated any COVID-19 pandemic by months. When BioNTech's mRNA COVID-19 vaccine — developed in partnership with Pfizer — became one of the most widely used vaccines in history, the investment returned an estimated $550 million. The timing cemented Gates's early conviction in mRNA as a platform technology.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Backs Merck rVSV-ZEBOV Ervebo — First Licensed Ebola Vaccine
Next →
Argued in the Washington Post that Africa's population growth without health investment would generate unprecedented migration pressure
Related Accomplishments
January 2024
Gates Uses Shell Companies to Quietly Accumulate $113 Million Nebraska Farmland Portfolio
A January 2024 investigation by The Guardian and Floodlight News revealed that entities connected to Bill Gates's Cascade Investment had used a network of limited liability companies — including Cottonwood Ag Management — to quietly purchase approximately 20,588 acres of Nebraska farmland valued at roughly $113 million, without disclosing the beneficial owner to local sellers or county officials. The acquisitions were part of Gates's wider strategy to become the largest private farmland owner in the United States, with holdings exceeding 269,000 acres across 18 states, managed through Cottonwood Ag Management and its parent Leading Harvest, which develops regenerative agriculture certification standards.
2024
Breakthrough Energy Ventures Raises $839 Million Fund III with Food and Agriculture Focus
Breakthrough Energy Ventures closed its third fund at $839 million, with food and agriculture as one of five core investment sectors alongside power, transportation, manufacturing, and buildings. The fund holds stakes in approximately 20 agricultural companies and requires each portfolio company to demonstrate a credible pathway to avoiding at least 500 million tons of CO₂-equivalent emissions annually by 2050. The 20-year investment horizon is deliberately longer than standard venture capital to reflect the time required to change biological and physical infrastructure at scale.
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.